Loading viewer...
earnings
Format: PDF earnings
Creo Medical Group plc presents FY2023 financial results and FY2024 outlook, highlighting total sales of £30.8m and 2.5x revenue increase from Speedboat Inject and CROMA products. The company achieved 49.6% gross margin and reduced underlying operating losses, with strong Q1-24 trading and growing consumables sales supporting continued growth plans.
earnings
11 Pages
Allgeier Holding AG
LSC Communications Q4 2016 Results February 2017
earningsearnings
15 Pages
LSC Communications
Pirelli 9M 2023 Financial Results Presentation
earningsearnings
33 Pages
Pirelli & C. S.p.A.
Century Aluminum Q3 2016 Earnings Call
earningsearnings
13 Pages
Century Aluminum Company